The renin-angiotensin system is overexpressed in hormone refractory prostate cancer and influenced by hormonal stimulation, suggesting a potential role in disease progression.
No takes yet. Share an insight, caveat, or question.
May implicate RAS in refractory progression; animal data leave open clinical translation and therapeutic testing.
Uemura et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: